Provectus Disappears 'Breakthrough' Drug Claim on Web Site

Did you notice the big change on the home page of Provectus Biopharmaceuticals' (PVCT) web site today?

Here's a screen shot of the site today. PV-10 is referred to as an "Investigational Drug for Cancer."



No big deal? Well, take a look at what Provectus' web site looked like yesterday:


PV-10 is a "Breakthrough Cancer Drug"? Really? That's news to all of us, given Provectus is supposed to hear back from the FDA this week about the request to grant PV-10 Breakthrough Therapy status for skin cancer. So far, Provectus has said nothing about the FDA's response. 

If Provectus hasn't heard from FDA yet on PV-10's "Breakthrough" status, why describe the drug on the home page of its web site as a "Breakthrough Cancer Drug"? Today, PV-10 is merely an "Investigational Drug." Maybe someone at the FDA caught a glance at Provectus' web site and slapped a wrist. We all know Provectus would never try to fool investors. Nah, this fine, upstanding company would never do something sneaky like tricking people into thinking PV-10 was granted Breakthrough Therapy status when it wasn't.


Adam Feuerstein writes regularly for TheStreet. In keeping with company editorial policy, he doesn't own or short individual stocks, although he owns stock in TheStreet. He also doesn't invest in hedge funds or other private investment partnerships. Feuerstein appreciates your feedback; click here to send him an email.

More from Investing

Short Disney Stock Here: Doug Kass Insider

Short Disney Stock Here: Doug Kass Insider

CHART: Even Consumer Staples Stocks Are Being Pummeled in Tuesday's Market Rout

CHART: Even Consumer Staples Stocks Are Being Pummeled in Tuesday's Market Rout

Why Google, Facebook and Other Tech Giants' Capital Spending Is Going Sky High

Why Google, Facebook and Other Tech Giants' Capital Spending Is Going Sky High

Starbucks Could Pay Some 'Seven Figures' If Wage Dispute Becomes Class Action

Starbucks Could Pay Some 'Seven Figures' If Wage Dispute Becomes Class Action

Bitcoin Today: Prices Surge Past $9,000 Mark as Rally Continues

Bitcoin Today: Prices Surge Past $9,000 Mark as Rally Continues